nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0978	0.282	CbGbCtD
Isradipine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0661	0.19	CbGbCtD
Isradipine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.063	0.182	CbGbCtD
Isradipine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0562	0.162	CbGbCtD
Isradipine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.033	0.0949	CbGbCtD
Isradipine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0311	0.0896	CbGbCtD
Isradipine—CACNA1C—Nicotine Activity on Chromaffin Cells—CHRNA3—chronic obstructive pulmonary disease	0.0184	0.165	CbGpPWpGaD
Isradipine—CACNA2D2—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.00462	0.0414	CbGpPWpGaD
Isradipine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00444	0.0399	CbGpPWpGaD
Isradipine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00393	0.0352	CbGpPWpGaD
Isradipine—CACNA1H—Corticotropin-releasing hormone—RAPGEF3—chronic obstructive pulmonary disease	0.00377	0.0339	CbGpPWpGaD
Isradipine—CACNA2D2—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00363	0.0326	CbGpPWpGaD
Isradipine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00321	0.0288	CbGpPWpGaD
Isradipine—CACNB2—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.00317	0.0284	CbGpPWpGaD
Isradipine—CACNA1D—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.003	0.0269	CbGpPWpGaD
Isradipine—CACNA1C—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.00263	0.0236	CbGpPWpGaD
Isradipine—CACNB2—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00249	0.0223	CbGpPWpGaD
Isradipine—CACNA1D—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00236	0.0212	CbGpPWpGaD
Isradipine—Clevidipine—CYP1A2—chronic obstructive pulmonary disease	0.00207	0.171	CrCbGaD
Isradipine—CACNA1C—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00207	0.0186	CbGpPWpGaD
Isradipine—Nisoldipine—CYP1A2—chronic obstructive pulmonary disease	0.00199	0.164	CrCbGaD
Isradipine—Nilvadipine—CYP1A2—chronic obstructive pulmonary disease	0.00186	0.154	CrCbGaD
Isradipine—CACNA2D2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00173	0.0156	CbGpPWpGaD
Isradipine—Amlodipine—CYP1A1—chronic obstructive pulmonary disease	0.00166	0.137	CrCbGaD
Isradipine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00163	0.0146	CbGpPWpGaD
Isradipine—Amlodipine—CYP1A2—chronic obstructive pulmonary disease	0.0016	0.132	CrCbGaD
Isradipine—Nifedipine—CYP1A1—chronic obstructive pulmonary disease	0.00148	0.123	CrCbGaD
Isradipine—Nifedipine—CYP1A2—chronic obstructive pulmonary disease	0.00143	0.118	CrCbGaD
Isradipine—CACNA2D2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00141	0.0127	CbGpPWpGaD
Isradipine—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.00258	CcSEcCtD
Isradipine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00136	0.00258	CcSEcCtD
Isradipine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00136	0.00257	CcSEcCtD
Isradipine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00135	0.00254	CcSEcCtD
Isradipine—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00253	CcSEcCtD
Isradipine—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00253	CcSEcCtD
Isradipine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00253	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.00251	CcSEcCtD
Isradipine—CACNA2D2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00133	0.0119	CbGpPWpGaD
Isradipine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.0025	CcSEcCtD
Isradipine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.0025	CcSEcCtD
Isradipine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00249	CcSEcCtD
Isradipine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00249	CcSEcCtD
Isradipine—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00249	CcSEcCtD
Isradipine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00248	CcSEcCtD
Isradipine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00248	CcSEcCtD
Isradipine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00246	CcSEcCtD
Isradipine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00246	CcSEcCtD
Isradipine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00244	CcSEcCtD
Isradipine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00129	0.00243	CcSEcCtD
Isradipine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00241	CcSEcCtD
Isradipine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00241	CcSEcCtD
Isradipine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00239	CcSEcCtD
Isradipine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00126	0.00238	CcSEcCtD
Isradipine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00238	CcSEcCtD
Isradipine—Cough—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00238	CcSEcCtD
Isradipine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00236	CcSEcCtD
Isradipine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00125	0.0112	CbGpPWpGaD
Isradipine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00236	CcSEcCtD
Isradipine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00235	CcSEcCtD
Isradipine—Cough—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00233	CcSEcCtD
Isradipine—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.00123	0.00233	CcSEcCtD
Isradipine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00123	0.00232	CcSEcCtD
Isradipine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00232	CcSEcCtD
Isradipine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00232	CcSEcCtD
Isradipine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00232	CcSEcCtD
Isradipine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00232	CcSEcCtD
Isradipine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00232	CcSEcCtD
Isradipine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00232	CcSEcCtD
Isradipine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00232	CcSEcCtD
Isradipine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00231	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00231	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00231	CcSEcCtD
Isradipine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.0023	CcSEcCtD
Isradipine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00122	0.0023	CcSEcCtD
Isradipine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00228	CcSEcCtD
Isradipine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00228	CcSEcCtD
Isradipine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00227	CcSEcCtD
Isradipine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00227	CcSEcCtD
Isradipine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00227	CcSEcCtD
Isradipine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.00226	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00226	CcSEcCtD
Isradipine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00225	CcSEcCtD
Isradipine—CACNB2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00119	0.0107	CbGpPWpGaD
Isradipine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00118	0.00223	CcSEcCtD
Isradipine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.00223	CcSEcCtD
Isradipine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00118	0.00223	CcSEcCtD
Isradipine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.00223	CcSEcCtD
Isradipine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00219	CcSEcCtD
Isradipine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00219	CcSEcCtD
Isradipine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00116	0.00219	CcSEcCtD
Isradipine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00219	CcSEcCtD
Isradipine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00218	CcSEcCtD
Isradipine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00218	CcSEcCtD
Isradipine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00115	0.00218	CcSEcCtD
Isradipine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00115	0.00218	CcSEcCtD
Isradipine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00217	CcSEcCtD
Isradipine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00217	CcSEcCtD
Isradipine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00217	CcSEcCtD
Isradipine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00216	CcSEcCtD
Isradipine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00216	CcSEcCtD
Isradipine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00215	CcSEcCtD
Isradipine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00214	CcSEcCtD
Isradipine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00214	CcSEcCtD
Isradipine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00212	CcSEcCtD
Isradipine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.0021	CcSEcCtD
Isradipine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.0021	CcSEcCtD
Isradipine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00208	CcSEcCtD
Isradipine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00208	CcSEcCtD
Isradipine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.0011	0.00207	CcSEcCtD
Isradipine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00207	CcSEcCtD
Isradipine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00206	CcSEcCtD
Isradipine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00205	CcSEcCtD
Isradipine—CACNA2D2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00108	0.00972	CbGpPWpGaD
Isradipine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00204	CcSEcCtD
Isradipine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00203	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00203	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00203	CcSEcCtD
Isradipine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00201	CcSEcCtD
Isradipine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00201	CcSEcCtD
Isradipine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00106	0.002	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00199	CcSEcCtD
Isradipine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00199	CcSEcCtD
Isradipine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00199	CcSEcCtD
Isradipine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00198	CcSEcCtD
Isradipine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00198	CcSEcCtD
Isradipine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00197	CcSEcCtD
Isradipine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00197	CcSEcCtD
Isradipine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00196	CcSEcCtD
Isradipine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00196	CcSEcCtD
Isradipine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00196	CcSEcCtD
Isradipine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00195	CcSEcCtD
Isradipine—CACNA1H—Corticotropin-releasing hormone—TLR4—chronic obstructive pulmonary disease	0.00103	0.00924	CbGpPWpGaD
Isradipine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00194	CcSEcCtD
Isradipine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00102	0.00194	CcSEcCtD
Isradipine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.00102	0.00193	CcSEcCtD
Isradipine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00192	CcSEcCtD
Isradipine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00192	CcSEcCtD
Isradipine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00192	CcSEcCtD
Isradipine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00192	CcSEcCtD
Isradipine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00192	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00192	CcSEcCtD
Isradipine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00101	0.0019	CcSEcCtD
Isradipine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.0019	CcSEcCtD
Isradipine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.0019	CcSEcCtD
Isradipine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.001	0.00189	CcSEcCtD
Isradipine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000997	0.00188	CcSEcCtD
Isradipine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000996	0.00188	CcSEcCtD
Isradipine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000992	0.00187	CcSEcCtD
Isradipine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00099	0.00187	CcSEcCtD
Isradipine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000987	0.00186	CcSEcCtD
Isradipine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000985	0.00186	CcSEcCtD
Isradipine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000981	0.00185	CcSEcCtD
Isradipine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00098	0.00185	CcSEcCtD
Isradipine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000977	0.00185	CcSEcCtD
Isradipine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000976	0.00184	CcSEcCtD
Isradipine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000972	0.00184	CcSEcCtD
Isradipine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000972	0.00184	CcSEcCtD
Isradipine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00097	0.00183	CcSEcCtD
Isradipine—CACNB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000969	0.0087	CbGpPWpGaD
Isradipine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000969	0.00869	CbGpPWpGaD
Isradipine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000968	0.00183	CcSEcCtD
Isradipine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000967	0.00183	CcSEcCtD
Isradipine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000966	0.00182	CcSEcCtD
Isradipine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000963	0.00182	CcSEcCtD
Isradipine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000961	0.00182	CcSEcCtD
Isradipine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00096	0.00181	CcSEcCtD
Isradipine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000952	0.0018	CcSEcCtD
Isradipine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000937	0.00177	CcSEcCtD
Isradipine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000937	0.00177	CcSEcCtD
Isradipine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000929	0.00175	CcSEcCtD
Isradipine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000921	0.00174	CcSEcCtD
Isradipine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00092	0.00174	CcSEcCtD
Isradipine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00092	0.00174	CcSEcCtD
Isradipine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000917	0.00173	CcSEcCtD
Isradipine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000917	0.00173	CcSEcCtD
Isradipine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000915	0.00173	CcSEcCtD
Isradipine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000915	0.00173	CcSEcCtD
Isradipine—CACNB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000911	0.00817	CbGpPWpGaD
Isradipine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000884	0.00167	CcSEcCtD
Isradipine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000868	0.00164	CcSEcCtD
Isradipine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000866	0.00164	CcSEcCtD
Isradipine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000846	0.0016	CcSEcCtD
Isradipine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000846	0.0016	CcSEcCtD
Isradipine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000841	0.00755	CbGpPWpGaD
Isradipine—CACNA1S—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000834	0.00749	CbGpPWpGaD
Isradipine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000834	0.00158	CcSEcCtD
Isradipine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000834	0.00158	CcSEcCtD
Isradipine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000829	0.00157	CcSEcCtD
Isradipine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000817	0.00154	CcSEcCtD
Isradipine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000807	0.00152	CcSEcCtD
Isradipine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000807	0.00152	CcSEcCtD
Isradipine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000799	0.00151	CcSEcCtD
Isradipine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00079	0.00149	CcSEcCtD
Isradipine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000788	0.00149	CcSEcCtD
Isradipine—CACNA1H—Corticotropin-releasing hormone—NOS3—chronic obstructive pulmonary disease	0.000787	0.00707	CbGpPWpGaD
Isradipine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00078	0.00147	CcSEcCtD
Isradipine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00078	0.00147	CcSEcCtD
Isradipine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000766	0.00687	CbGpPWpGaD
Isradipine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000764	0.00144	CcSEcCtD
Isradipine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000762	0.00144	CcSEcCtD
Isradipine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000751	0.00142	CcSEcCtD
Isradipine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00075	0.00142	CcSEcCtD
Isradipine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00075	0.00142	CcSEcCtD
Isradipine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000743	0.0014	CcSEcCtD
Isradipine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000743	0.0014	CcSEcCtD
Isradipine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000743	0.0014	CcSEcCtD
Isradipine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000743	0.0014	CcSEcCtD
Isradipine—CACNB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000743	0.00666	CbGpPWpGaD
Isradipine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000743	0.0014	CcSEcCtD
Isradipine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000739	0.0014	CcSEcCtD
Isradipine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000739	0.0014	CcSEcCtD
Isradipine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000737	0.00139	CcSEcCtD
Isradipine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000736	0.00139	CcSEcCtD
Isradipine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000734	0.00139	CcSEcCtD
Isradipine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000733	0.00658	CbGpPWpGaD
Isradipine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000728	0.00138	CcSEcCtD
Isradipine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000727	0.00137	CcSEcCtD
Isradipine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000726	0.00137	CcSEcCtD
Isradipine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000725	0.00137	CcSEcCtD
Isradipine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000723	0.00137	CcSEcCtD
Isradipine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000717	0.00135	CcSEcCtD
Isradipine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000715	0.00135	CcSEcCtD
Isradipine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000713	0.00135	CcSEcCtD
Isradipine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000708	0.00134	CcSEcCtD
Isradipine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000705	0.00133	CcSEcCtD
Isradipine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000704	0.00632	CbGpPWpGaD
Isradipine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000702	0.00133	CcSEcCtD
Isradipine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000702	0.00133	CcSEcCtD
Isradipine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000701	0.00132	CcSEcCtD
Isradipine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.0007	0.00132	CcSEcCtD
Isradipine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.0007	0.00132	CcSEcCtD
Isradipine—CACNA1H—Corticotropin-releasing hormone—CXCL8—chronic obstructive pulmonary disease	0.000698	0.00627	CbGpPWpGaD
Isradipine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000697	0.00132	CcSEcCtD
Isradipine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000688	0.0013	CcSEcCtD
Isradipine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000686	0.0013	CcSEcCtD
Isradipine—CACNA1D—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000677	0.00608	CbGpPWpGaD
Isradipine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000677	0.00607	CbGpPWpGaD
Isradipine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000665	0.00126	CcSEcCtD
Isradipine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000661	0.00125	CcSEcCtD
Isradipine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000658	0.00124	CcSEcCtD
Isradipine—CACNA1S—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000642	0.00576	CbGpPWpGaD
Isradipine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000642	0.00121	CcSEcCtD
Isradipine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000638	0.00121	CcSEcCtD
Isradipine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000638	0.00121	CcSEcCtD
Isradipine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000628	0.00119	CcSEcCtD
Isradipine—CACNA2D2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000627	0.00563	CbGpPWpGaD
Isradipine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000623	0.00118	CcSEcCtD
Isradipine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000617	0.00117	CcSEcCtD
Isradipine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000611	0.00549	CbGpPWpGaD
Isradipine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00061	0.00115	CcSEcCtD
Isradipine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000606	0.00114	CcSEcCtD
Isradipine—CACNA1C—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000595	0.00534	CbGpPWpGaD
Isradipine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000592	0.00112	CcSEcCtD
Isradipine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.00059	0.00111	CcSEcCtD
Isradipine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000587	0.00527	CbGpPWpGaD
Isradipine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000577	0.00109	CcSEcCtD
Isradipine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000573	0.00108	CcSEcCtD
Isradipine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000572	0.00108	CcSEcCtD
Isradipine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000568	0.00107	CcSEcCtD
Isradipine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000556	0.00499	CbGpPWpGaD
Isradipine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000536	0.00101	CcSEcCtD
Isradipine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000527	0.000996	CcSEcCtD
Isradipine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000526	0.000994	CcSEcCtD
Isradipine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000525	0.000993	CcSEcCtD
Isradipine—CACNA1D—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000521	0.00468	CbGpPWpGaD
Isradipine—CACNA1H—Corticotropin-releasing hormone—TGFB1—chronic obstructive pulmonary disease	0.000521	0.00467	CbGpPWpGaD
Isradipine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000519	0.000981	CcSEcCtD
Isradipine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000513	0.000968	CcSEcCtD
Isradipine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000511	0.00459	CbGpPWpGaD
Isradipine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00051	0.000963	CcSEcCtD
Isradipine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000507	0.000958	CcSEcCtD
Isradipine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.0005	0.000944	CcSEcCtD
Isradipine—CACNA1H—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.0005	0.00448	CbGpPWpGaD
Isradipine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000492	0.00441	CbGpPWpGaD
Isradipine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000484	0.000914	CcSEcCtD
Isradipine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000482	0.000911	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000481	0.000908	CcSEcCtD
Isradipine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000478	0.000903	CcSEcCtD
Isradipine—CACNA1S—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000466	0.00418	CbGpPWpGaD
Isradipine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000464	0.000877	CcSEcCtD
Isradipine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000464	0.000877	CcSEcCtD
Isradipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00046	0.00413	CbGpPWpGaD
Isradipine—CACNA1C—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000458	0.00411	CbGpPWpGaD
Isradipine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000456	0.000862	CcSEcCtD
Isradipine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000455	0.00086	CcSEcCtD
Isradipine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000453	0.000855	CcSEcCtD
Isradipine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000451	0.000851	CcSEcCtD
Isradipine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000449	0.000847	CcSEcCtD
Isradipine—CACNA1H—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000441	0.00396	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—APIP—chronic obstructive pulmonary disease	0.00043	0.00386	CbGpPWpGaD
Isradipine—CACNA1S—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000424	0.0038	CbGpPWpGaD
Isradipine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000423	0.000799	CcSEcCtD
Isradipine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000422	0.000798	CcSEcCtD
Isradipine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00042	0.000793	CcSEcCtD
Isradipine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000417	0.000787	CcSEcCtD
Isradipine—CACNA2D2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000415	0.00373	CbGpPWpGaD
Isradipine—CACNA1S—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000411	0.00369	CbGpPWpGaD
Isradipine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000408	0.000772	CcSEcCtD
Isradipine—CACNA1D—Metabolism—APIP—chronic obstructive pulmonary disease	0.000407	0.00365	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GC—chronic obstructive pulmonary disease	0.000404	0.00362	CbGpPWpGaD
Isradipine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000403	0.000762	CcSEcCtD
Isradipine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000403	0.000761	CcSEcCtD
Isradipine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000402	0.00076	CcSEcCtD
Isradipine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.0004	0.000756	CcSEcCtD
Isradipine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.0004	0.000756	CcSEcCtD
Isradipine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000397	0.00075	CcSEcCtD
Isradipine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000382	0.000722	CcSEcCtD
Isradipine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000379	0.000716	CcSEcCtD
Isradipine—CACNA1D—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000378	0.0034	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000375	0.00337	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000374	0.00336	CbGpPWpGaD
Isradipine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000369	0.000696	CcSEcCtD
Isradipine—CACNB2—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000363	0.00326	CbGpPWpGaD
Isradipine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000361	0.00324	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—APIP—chronic obstructive pulmonary disease	0.000357	0.00321	CbGpPWpGaD
Isradipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000344	0.00309	CbGpPWpGaD
Isradipine—CACNA1D—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000334	0.00299	CbGpPWpGaD
Isradipine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000333	0.000629	CcSEcCtD
Isradipine—CACNA1C—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000332	0.00298	CbGpPWpGaD
Isradipine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000328	0.00062	CcSEcCtD
Isradipine—CACNB2—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000321	0.00288	CbGpPWpGaD
Isradipine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000317	0.0006	CcSEcCtD
Isradipine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000307	0.00058	CcSEcCtD
Isradipine—CACNA1D—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000304	0.00273	CbGpPWpGaD
Isradipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000302	0.00271	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000299	0.00268	CbGpPWpGaD
Isradipine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000295	0.000557	CcSEcCtD
Isradipine—CACNA1C—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000293	0.00263	CbGpPWpGaD
Isradipine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000293	0.000553	CcSEcCtD
Isradipine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000292	0.000552	CcSEcCtD
Isradipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000292	0.00262	CbGpPWpGaD
Isradipine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000291	0.000549	CcSEcCtD
Isradipine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000288	0.00259	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000285	0.00255	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GC—chronic obstructive pulmonary disease	0.000277	0.00248	CbGpPWpGaD
Isradipine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000276	0.000521	CcSEcCtD
Isradipine—CACNA1H—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000274	0.00246	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000269	0.00242	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000267	0.0024	CbGpPWpGaD
Isradipine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000263	0.00236	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GC—chronic obstructive pulmonary disease	0.000262	0.00235	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000257	0.00231	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000244	0.00219	CbGpPWpGaD
Isradipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000237	0.00213	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000237	0.00213	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000232	0.00209	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000231	0.00207	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GC—chronic obstructive pulmonary disease	0.00023	0.00207	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000221	0.00198	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000218	0.00196	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000214	0.00192	CbGpPWpGaD
Isradipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000212	0.00191	CbGpPWpGaD
Isradipine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00021	0.00188	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000207	0.00186	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000199	0.00179	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000199	0.00179	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000196	0.00176	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000189	0.00169	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000186	0.00167	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.00165	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000176	0.00158	CbGpPWpGaD
Isradipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000172	0.00154	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000168	0.00151	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000166	0.00149	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000165	0.00148	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000159	0.00143	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000158	0.00142	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000153	0.00137	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000151	0.00136	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000151	0.00136	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000151	0.00135	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000151	0.00135	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00015	0.00134	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000149	0.00134	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000148	0.00133	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000143	0.00129	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000143	0.00129	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000143	0.00128	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000142	0.00127	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000141	0.00126	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.00014	0.00125	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.00014	0.00125	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000136	0.00122	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.000136	0.00122	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000136	0.00122	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000133	0.0012	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—EGFR—chronic obstructive pulmonary disease	0.000133	0.00119	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000129	0.00116	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000128	0.00115	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—TNF—chronic obstructive pulmonary disease	0.000127	0.00114	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.00113	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000126	0.00113	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.00113	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000125	0.00113	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000125	0.00113	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000124	0.00112	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000124	0.00111	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000122	0.00109	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.00012	0.00107	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000119	0.00107	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.000115	0.00103	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000114	0.00102	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000113	0.00102	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—EGFR—chronic obstructive pulmonary disease	0.000113	0.00101	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000113	0.00101	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000108	0.000965	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—TNF—chronic obstructive pulmonary disease	0.000108	0.000965	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000105	0.000942	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000105	0.000941	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000105	0.000939	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000104	0.000936	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000104	0.000929	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000103	0.000928	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—IL6—chronic obstructive pulmonary disease	0.000102	0.000918	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000102	0.000914	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MMP9—chronic obstructive pulmonary disease	9.97e-05	0.000894	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.93e-05	0.000891	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—IL6—chronic obstructive pulmonary disease	9.87e-05	0.000886	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	9.87e-05	0.000886	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.79e-05	0.000879	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—EGFR—chronic obstructive pulmonary disease	9.68e-05	0.000869	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.65e-05	0.000866	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.63e-05	0.000865	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.51e-05	0.000854	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	9.35e-05	0.000839	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—TNF—chronic obstructive pulmonary disease	9.22e-05	0.000827	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—EGFR—chronic obstructive pulmonary disease	9.17e-05	0.000823	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.14e-05	0.000821	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.13e-05	0.00082	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.12e-05	0.000819	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ALB—chronic obstructive pulmonary disease	9.06e-05	0.000813	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.02e-05	0.000809	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	8.95e-05	0.000803	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—TNF—chronic obstructive pulmonary disease	8.73e-05	0.000783	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.72e-05	0.000783	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—IL6—chronic obstructive pulmonary disease	8.68e-05	0.000779	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—IL6—chronic obstructive pulmonary disease	8.67e-05	0.000778	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—NOS3—chronic obstructive pulmonary disease	8.66e-05	0.000777	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.65e-05	0.000776	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.6e-05	0.000772	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	8.21e-05	0.000737	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—EGFR—chronic obstructive pulmonary disease	8.05e-05	0.000723	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.02e-05	0.000719	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—TNF—chronic obstructive pulmonary disease	7.67e-05	0.000688	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.6e-05	0.000682	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—IL6—chronic obstructive pulmonary disease	7.44e-05	0.000668	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	7.36e-05	0.00066	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—IL6—chronic obstructive pulmonary disease	7.04e-05	0.000632	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ALB—chronic obstructive pulmonary disease	6.21e-05	0.000557	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—IL6—chronic obstructive pulmonary disease	6.19e-05	0.000555	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.94e-05	0.000533	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ALB—chronic obstructive pulmonary disease	5.88e-05	0.000528	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—NOS3—chronic obstructive pulmonary disease	5.62e-05	0.000505	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ALB—chronic obstructive pulmonary disease	5.17e-05	0.000464	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NOS3—chronic obstructive pulmonary disease	4.94e-05	0.000443	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.87e-05	0.000437	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.74e-05	0.000425	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.41e-05	0.000395	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.59e-05	0.000232	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.56e-05	0.00023	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.34e-05	0.00021	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.15e-05	0.000193	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.79e-05	0.000161	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.77e-05	0.000159	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.65e-05	0.000148	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.56e-05	0.00014	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.06e-05	9.54e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.02e-05	9.12e-05	CbGpPWpGaD
